Stockreport

Bristol-Myers Squibb applications for new use of O+Y accepted in U.S. and Europe [Seeking Alpha]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF The FDA and EMA (European Medicines Agency) haveaccepted for reviewBMYThe FDA's action date is August 6.The company's partner in Japan, Ono Pharmaceutical Co., filed a m [Read more]